MXPA02007039A - Crecimiento ocular y antagonistas nicotinicos. - Google Patents

Crecimiento ocular y antagonistas nicotinicos.

Info

Publication number
MXPA02007039A
MXPA02007039A MXPA02007039A MXPA02007039A MXPA02007039A MX PA02007039 A MXPA02007039 A MX PA02007039A MX PA02007039 A MXPA02007039 A MX PA02007039A MX PA02007039 A MXPA02007039 A MX PA02007039A MX PA02007039 A MXPA02007039 A MX PA02007039A
Authority
MX
Mexico
Prior art keywords
nicotinic antagonists
ocular growth
ocular
growth
nicotinic
Prior art date
Application number
MXPA02007039A
Other languages
English (en)
Spanish (es)
Inventor
Richard A Stone
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of MXPA02007039A publication Critical patent/MXPA02007039A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4747—Quinolines; Isoquinolines spiro-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA02007039A 2000-01-18 2001-01-18 Crecimiento ocular y antagonistas nicotinicos. MXPA02007039A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17687500P 2000-01-18 2000-01-18
PCT/US2001/001692 WO2001052832A1 (fr) 2000-01-18 2001-01-18 Croissance oculaire et antagonistes nicotiniques

Publications (1)

Publication Number Publication Date
MXPA02007039A true MXPA02007039A (es) 2003-09-25

Family

ID=22646232

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02007039A MXPA02007039A (es) 2000-01-18 2001-01-18 Crecimiento ocular y antagonistas nicotinicos.

Country Status (10)

Country Link
EP (1) EP1272170A1 (fr)
JP (1) JP2003520228A (fr)
KR (1) KR20020081260A (fr)
CN (1) CN1418095A (fr)
AU (1) AU775516B2 (fr)
CA (1) CA2400803A1 (fr)
HK (1) HK1052464A1 (fr)
MX (1) MXPA02007039A (fr)
RU (1) RU2002120485A (fr)
WO (1) WO2001052832A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007075720A2 (fr) * 2005-12-19 2007-07-05 Comentis, Inc. Preparations de mecamylamine topique pour administration oculaire et utilisations de celles-ci
FI20075498A (fi) 2007-06-29 2008-12-30 Eero Castren Menetelmä amblyopian hoitamiseksi masennuslääkkeillä
EP3593817A4 (fr) 2017-03-06 2021-04-07 Tsubota Laboratory, Inc. Modèle murin d'induction de la myopie et inhibiteur de stress du réticulum endoplasmique pour prévenir ou supprimer la myopie
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
CA3138008A1 (fr) 2019-04-17 2020-10-22 Compass Pathfinder Limited Procedes pour traiter les troubles neurocognitifs, la douleur chronique, et pour reduire l'inflammation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69029734T2 (de) * 1989-06-21 1997-05-28 Univ Pennsylvania Verwendung von Pirenzepine, Telenzepine oder O-Methoxy -sila-hexocyclium zur Herstellung eines Medikaments zur BEHANDLUNG UND REGULIERUNG DER AUGENENTWICKLUNG
US6710051B1 (en) * 1997-01-06 2004-03-23 Klaus Trier Aps Screening method

Also Published As

Publication number Publication date
KR20020081260A (ko) 2002-10-26
CA2400803A1 (fr) 2001-07-26
HK1052464A1 (zh) 2003-09-19
AU775516B2 (en) 2004-08-05
JP2003520228A (ja) 2003-07-02
AU3096901A (en) 2001-07-31
EP1272170A1 (fr) 2003-01-08
WO2001052832A1 (fr) 2001-07-26
RU2002120485A (ru) 2004-04-10
CN1418095A (zh) 2003-05-14

Similar Documents

Publication Publication Date Title
AU9684401A (en) Hedgehog antagonists, methods and uses related thereto
DE60141136D1 (en) Selektive photocoagulation
MXPA03001928A (es) Derivados de quinolina y quinazolina.
HUP0301243A3 (en) Herbicidal substituted pyridine-ketones, preparation and use thereof
ZA200205557B (en) 4-Aminopicolinates and their use as herbicides.
PL365787A1 (en) Heterocyclic compounds, their production and use
ZA200109189B (en) Artificial stone and formation thereof.
AU2001288720A1 (en) Implantable article
MXPA03000738A (es) Antagonistas de grelina.
GB2361235B (en) 2,2,6,6 Diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides
EP1333853A4 (fr) Complexe du facteur de croissance
MXPA03004932A (es) 2-anilino-bencimidazoles sustituidos y su uso como inhibidores de nhe.
HK1054036A1 (en) Substituted 3-phenyl-5-alkoxi-1, 3, 4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase
EP1210084A4 (fr) Pyridomorphinanes, thienomorphinanes et utilisation
NZ513917A (en) 1-aryl-1,3,5-triazine-4-thione-2,6-diones, production thereof and use thereof as herbicides
HK1048318A1 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors.
AU2001266939A1 (en) Biocidal polyamides and methods
AU146195S (en) An eyeshield
MXPA02007039A (es) Crecimiento ocular y antagonistas nicotinicos.
HUP0302676A3 (en) Improved insecticidal bacteria, and methods for making and using them
MXPA03001951A (es) Pirroliminas y pirazoliminas fusionadas substituidas.
AU146196S (en) An eyeshield
AU2001294776A1 (en) Lactone integrin antagonists
AU7815201A (en) Synthetic salicylihalamides, apicularens and derivatives thereof
AU2002230744A1 (en) Tapered microkeratome head

Legal Events

Date Code Title Description
GB Transfer or rights
FG Grant or registration